FURAZOLIDONE

Fetal Risk Summary

No reports linking the use of furazolidone with congenital defects have been located. The Collaborative Perinatal Project monitored 50,282 mother-child pairs, 132 of whom had 1st trimester exposure to furazolidone (1). No association with malformations was found. Theoretically, furazolidone could produce hemolytic anemia in a glucose-6-phosphate dehydrogenase-deficient newborn if given at term. Placental passage of the drug has not been reported.

Breast Feeding Summary

No data are available.

Reference